Keith Thompson is the current chair of biotech start-up NK:IO. He’s also chair of the Pharma Advisory Board of Deep Science Ventures and acted as industry advisor to the Vaccines Taskforce. Prior to this, Keith has had a rich career in biotech, with 8 years as CEO of The Cell and Gene Therapy Catapult, and […]
read moreFounded by Gilad Gershon and Dr Eyal Maori, Tropic Biosciences uses cutting-edge technologies to develop tropical crop varieties with enhanced nutritional benefits, improved cultivation efficiencies, and, importantly, greater sustainability. With COP26 underway, and the need to reduce agriculture’s environmental impact becoming increasingly urgent, our attention turns to companies developing the novel technologies that promise greener […]
read moreUKI2S Chair, Andrew Mackintosh In the lead up to COP26, Andrew Mackintosh, the newly appointed Chair of UK Innovation and Science Seed Fund (UKI2S) Advisory Board, shares his insights on how best to support the fund’s role in supporting the development of new and innovative technologies that will help us reach our goal of Net […]
read more